These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 10566114)
21. Randomized controlled double-blind trial of optimal dose methylphenidate in children and adolescents with severe attention deficit hyperactivity disorder and intellectual disability. Simonoff E; Taylor E; Baird G; Bernard S; Chadwick O; Liang H; Whitwell S; Riemer K; Sharma K; Sharma SP; Wood N; Kelly J; Golaszewski A; Kennedy J; Rodney L; West N; Walwyn R; Jichi F J Child Psychol Psychiatry; 2013 May; 54(5):527-35. PubMed ID: 22676856 [TBL] [Abstract][Full Text] [Related]
22. Effects of stimulant medication on cognitive performance of children with ADHD. Gimpel GA; Collett BR; Veeder MA; Gifford JA; Sneddon P; Bushman B; Hughes K; Odell JD Clin Pediatr (Phila); 2005 Jun; 44(5):405-11. PubMed ID: 15965546 [TBL] [Abstract][Full Text] [Related]
23. Stimulant medication effects in a summer treatment program among young children with attention-deficit/hyperactivity disorder. Chacko A; Pelham WE; Gnagy EM; Greiner A; Vallano G; Bukstein O; Rancurello M J Am Acad Child Adolesc Psychiatry; 2005 Mar; 44(3):249-57. PubMed ID: 15725969 [TBL] [Abstract][Full Text] [Related]
24. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Aman MG; Binder C; Turgay A J Child Adolesc Psychopharmacol; 2004; 14(2):243-54. PubMed ID: 15319021 [TBL] [Abstract][Full Text] [Related]
25. Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome. Martens MA; Seyfer DL; Andridge RR; Foster JE; McClure KE; Coury DL Res Dev Disabil; 2013 May; 34(5):1700-9. PubMed ID: 23500164 [TBL] [Abstract][Full Text] [Related]
26. Symposium: behavior modification by drugs. II. Psychological effects of stimulant drugs in children with minimal brain dysfunction. Conners CK Pediatrics; 1972 May; 49(5):702-8. PubMed ID: 4402496 [No Abstract] [Full Text] [Related]
27. Preschool attention deficit hyperactivity disorder: a review of prevalence, diagnosis, neurobiology, and stimulant treatment. Connor DF J Dev Behav Pediatr; 2002 Feb; 23(1 Suppl):S1-9. PubMed ID: 11875284 [TBL] [Abstract][Full Text] [Related]
28. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD. Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544 [TBL] [Abstract][Full Text] [Related]
29. Pemoline effects on children with ADHD: a time-response by dose-response analysis on classroom measures. Pelham WE; Swanson JM; Furman MB; Schwindt H J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1504-13. PubMed ID: 8543519 [TBL] [Abstract][Full Text] [Related]
30. Pemoline in ADHD. Winsberg B; Barbato M J Am Acad Child Adolesc Psychiatry; 1997 Dec; 36(12):1649-50. PubMed ID: 9401321 [No Abstract] [Full Text] [Related]
31. The impact of methylphenidate on seizure frequency and severity in children with attention-deficit-hyperactivity disorder and difficult-to-treat epilepsies. Santos K; Palmini A; Radziuk AL; Rotert R; Bastos F; Booij L; Fernandes BS Dev Med Child Neurol; 2013 Jul; 55(7):654-60. PubMed ID: 23480530 [TBL] [Abstract][Full Text] [Related]
32. An update on central nervous system stimulant formulations in children and adolescents with attention-deficit/hyperactivity disorder. Chavez B; Sopko MA; Ehret MJ; Paulino RE; Goldberg KR; Angstadt K; Bogart GT Ann Pharmacother; 2009 Jun; 43(6):1084-95. PubMed ID: 19470858 [TBL] [Abstract][Full Text] [Related]
33. Equivalent effects of stimulant treatment for attention-deficit hyperactivity disorder during childhood and adolescence. Smith BH; Pelham WE; Gnagy E; Yudell RS J Am Acad Child Adolesc Psychiatry; 1998 Mar; 37(3):314-21. PubMed ID: 9519637 [TBL] [Abstract][Full Text] [Related]
34. Developmental aspects of psychostimulant treatment in children and adolescents with attention-deficit/hyperactivity disorder. Findling RL; Short EJ; Manos MJ J Am Acad Child Adolesc Psychiatry; 2001 Dec; 40(12):1441-7. PubMed ID: 11765290 [TBL] [Abstract][Full Text] [Related]
35. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review. Findling RL Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941 [TBL] [Abstract][Full Text] [Related]
37. How high a dose of stimulant medication in adult attention deficit hyperactivity disorder? Sachdev PS; Trollor JN Aust N Z J Psychiatry; 2000 Aug; 34(4):645-50. PubMed ID: 10954396 [TBL] [Abstract][Full Text] [Related]
38. Pemoline-associated hepatic failure: a critical analysis of the literature. Shevell M; Schreiber R Pediatr Neurol; 1997 Jan; 16(1):14-6. PubMed ID: 9044395 [TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)]. Golubchik P; Sever J; Weizman A Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124 [TBL] [Abstract][Full Text] [Related]
40. A rare case of dependence on pemoline. Bonnet U; Davids E Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]